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Purpose: Lifestyle intervention studies performed during pregnancy have shown inconsistent 
results in relation to prevention of gestational diabetes mellitus (GDM). Therefore, the aim 
of this study was to assess the effect of an intervention initiated already before pregnancy in 
prevention of GDM in high-risk women.
Patients and methods: A randomized controlled trial was conducted in four Finnish mater-
nity hospitals between the years 2008 and 2014. Altogether 228 high-risk women planning 
pregnancy were randomized to an intervention (n=116) or a control group (n=112). The risk 
factors were body mass index $30 kg/m2 (n=46), prior GDM (n=120), or both (n=62), without 
manifest diabetes at study inclusion. Trained study nurses provided individualized lifestyle 
counseling every 3 months in addition to a group session with a dietician. The control group 
received standard antenatal care. GDM was defined as one or more pathological glucose values 
in a 75 g 2-hour oral glucose tolerance test, performed between 12 and 16 weeks of gestation 
and if normal repeated between 24 and 28 weeks of gestation.
Results: Within 12 months, 67% of the women (n=72) in the intervention group and 63% of 
the women (n=71) in the control group (p=0.84) became pregnant. The cumulative incidence of 
GDM among the women available for the final analyses was 60% (n=39/65) in the intervention 
group and 54% (n=34/63) in the control group (p=0.49). GDM was diagnosed already before 
20 weeks of gestation in 60% (n=44/73) of the cases.
Conclusion: The preconceptional lifestyle intervention applied in the present study did not 
reduce the incidence of GDM.
Keywords: preconception, pregnancy, obesity, nutrition, physical activity
Introduction
During the last decades, both prevalence of overweight and obesity1 and consequently 
the incidence of gestational diabetes mellitus (GDM) have increased.2 GDM refers to 
glucose intolerance that is first recognized during pregnancy.3 Both genetic predisposi-
tion and environmental risk factors play a role in its pathogenesis.4 High body mass 
index (BMI)5 and prior GDM6 are associated with an increased GDM risk. Obesity and 
gestational diabetes are independent risk factors for several short-term7–9 and long-term 
adverse maternal and neonatal outcomes, including type 2 diabetes (T2D).10–12
Lifestyle interventions are known to be effective in the prevention of T2D,13 but studies 
assessing the effect of such interventions during pregnancy on perinatal and neonatal 
outcomes have produced inconsistent results.14–18 In 2015, a Cochrane review assessing 
combined diet and exercise interventions during pregnancy aiming at prevention of 
GDM and associated adverse outcomes concluded that no effect had been seen on the 
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development of GDM, the rate of caesarean sections, or large-
for-gestational-age newborns.19 A more recent meta-analysis 
with data including 11,487 pregnant women concluded, how-
ever, that lifestyle interventions initiated before 15 weeks of 
gestation reduced the risk of GDM by 20%.20 Furthermore, 
adherence to a healthy lifestyle both before and during preg-
nancy is associated with a lower GDM risk.21,22 As reviewed 
by Catalano and deMouzon,23 maternal prepregnancy and 
early pregnancy metabolic conditions program early placental 
function and increase the expression of maternal lipogenic 
and inflammatory genes related to complications of fetal 
overgrowth and GDM. Thus, an intervention initiated before 
pregnancy could theoretically have a significant impact on the 
incidence of GDM and related complications.
This study is part of the Finnish Gestational Diabetes 
Prevention Study (RADIEL) that aimed to prevent GDM and 
its complications in high-risk women through a combined 
physical activity and dietary intervention initiated either 
before pregnancy or during early pregnancy. The interven-
tion that was initiated during early pregnancy succeeded 
in reducing GDM incidence by 36% among women with 
normal oral glucose tolerance test (OGTT) in the first half 
of pregnancy.24 In this manuscript, we present the results of 
the high-risk study population in which the intervention was 
initiated already in the prepregnancy period with the aim to 
reduce the prevalence of GDM. To our knowledge, no pre-
vious randomized study with the aim to prevent GDM with 
a lifestyle intervention initiated in the prepregnancy period 
has been published.
Patients and methods
The Finnish RADIEL study is a multicenter randomized 
controlled trial conducted between February 2008 and 
January 2014 targeting women at high risk for GDM. 
The study took place in the three maternity hospitals of 
the Helsinki metropolitan area (Department of Obstetrics 
and Gynecology, Helsinki University Hospital (HUH); 
Kätilöopisto Maternity Hospital; and Jorvi Hospital) and in 
the South Karelia Central Hospital (SKCH), Lappeenranta, 
Finland. The study was designed to evaluate the efficacy of 
a combined diet and physical activity intervention in GDM 
prevention. The intervention design and methods have been 
published in detail elsewhere.25 This study focuses on the 
part of the RADIEL study in which the intervention was 
initiated before pregnancy.
Participants
Eligible participants were women aged 18 years or older, 
planning pregnancy within 1 year, with BMI $30 kg/m2 
or a previous history of GDM, and with no overt diabetes 
at inclusion. T2D at inclusion was defined as fasting 
plasma glucose $7.0 mmol/L, 2-hour plasma glucose 
level $11.1 mmol/L in a 75 g OGTT, or glycated hemo-
globin (HbA
1c
) $48 mmol/mol.3 Other exclusion criteria 
were use of medication that influences glucose metabolism 
(such as continuous oral corticosteroids or metformin), 
multiple pregnancy, physical disability, current substance 
abuse, severe psychiatric disorder, and significant diffi-
culty to cooperate (such as insufficient Finnish language 
skill). The women who did not become pregnant within 
1 year from their first visit were excluded from further 
analyses. Personal invitation letters were sent out based 
on hospital registry data, and notices in antenatal clinics, 
newspapers, and social media served as additional means 
for recruitment.
In the randomization procedure, we used computer-
generated randomly permuted blocks, stratified by risk 
factors used as inclusion criteria (BMI $30 kg/m2, prior 
diet-treated GDM, and prior drug-treated GDM) and the 
four study sites (ie, 12 strata in total). An independent stat-
istician outside the study group created the randomization 
sequence and prepared the opaque randomization envelopes. 
Study nurses then allocated each participant to the next 
sequentially numbered subject code and the corresponding 
envelope in the appropriate stratum containing information 
on the intervention arm.
Intervention
Participants visited the study nurse once every 3 months 
before pregnancy. During pregnancy, they had structured 
educational visits with the study nurse once in each trimes-
ter in addition to visits to local antenatal clinics according 
to standard practice. During the study visits, those in the 
intervention arm received individually modifiable dietary 
and physical activity counseling from trained study nurses. 
For example, if during pregnancy there were problems such 
as antenatal contractions and the participant was unable to 
exercise, the counseling focused more on dietary aspects. At 
each study visit, participants also filled in questionnaires and 
underwent a physical examination that included anthropo-
metric and blood pressure measurements and collection of 
blood samples as described in detail elsewhere.25 In addition, 
participants in the intervention arm attended a group visit 
with a dietician at the time of study enrollment.
Dietary counseling in the intervention group focused 
on encouraging the use of vegetables, fruits, and berries; 
high-fiber whole grain products; low-fat dairy products; 
vegetable fats high in unsaturated fatty acids; fish and 
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low-fat meat products; and lower intake of sugar-rich foods.26 
The recommendation for physical activity in the interven-
tion group aimed at achieving a minimum of 150 minutes of 
moderate intensity physical activity in a week27 and adopting 
an overall active lifestyle, for example, by increasing house-
hold and commuting physical activity. With the assistance 
of a study nurse, each participant planned an individual-
ized physical activity program that was updated during the 
follow-up.
In the intervention group, a 5%–10% weight loss 
before pregnancy was recommended for women with 
BMI $25 kg/m2 at inclusion. Avoidance of weight gain 
during the first two trimesters was recommended for women 
with a prepregnancy BMI $30 kg/m2.
Usual care
In the control group, participants had the same number of 
visits to the study nurse as the participants in the interven-
tion arm. They also completed the same questionnaires, 
and the same measurements were taken. At inclusion, they 
received information leaflets on healthy diet and exercise 
similar to those routinely provided by local antenatal clinics. 
In addition, the participants in both groups received usual 
antenatal care provided to all Finnish pregnant women by 
public primary healthcare centers. The usual care in the 
primary health care at the time of the trial included 10–15 
visits to a nurse and two to three visits to a physician during 
pregnancy.
Outcomes
The primary end point was incidence of GDM. During 
pregnancy, participants underwent a 75 g 2-hour OGTT at 
~12–16 weeks of gestation, and if normal, it was repeated 
at ~24–28 weeks of gestation unless insulin or metformin 
treatment was initiated earlier. GDM was diagnosed based 
on one or more pathological glucose values in the OGTT. 
The diagnostic thresholds were the same as recommended 
by the American Diabetes Association at the time of the 
study: fasting plasma glucose $5.3 mmol/L, 1-hour value 
$10.0 mmol/L, and 2-hour value $8.6 mmol/L.28 Preec-
lampsia was defined as SBP of $140 mmHg or DBP of 
$90 mmHg occurring after 20 weeks of gestation combined 
with diurnal proteinuria of $0.3 g.29 Pregnancy-induced 
hypertension was defined similarly but without the pres-
ence of proteinuria. Essential hypertension was defined with 
similar blood pressure levels occurring before 20 weeks of 
gestation. Study physicians reviewed the obstetric records 
of all participants and confirmed maternal and perinatal 
diagnoses prior to end point analysis.
The overall quality of diet was assessed with a dietary 
index (the maximum points being 17) based on a food 
frequency questionnaire designed for this study that measured 
the general adherence to the recommended diet.30 Evaluation 
of leisure time physical activity (LTPA) was based on the 
self-reported weekly duration of LTPA that made the partici-
pant at least slightly out of breath and sweating.31
statistics
The data are presented as mean (SD) or frequencies (%). An 
unpaired t-test for continuous variables and chi-squared test 
for categorical variables were used in comparisons between 
groups. We applied a logistic regression and an analysis for 
covariance model for adjustments of age, BMI, prior GDM 
status, the length of intervention before pregnancy (ie, time 
between the baseline visit and conception), and in addition 
for baseline values. In the case of violation of the assumptions 
(such as nonnormality), a bootstrap-type t-test was used. The 
Shapiro–Wilk W-test was used to test the normality of the 
data. All analyses were performed using STATA software, 
version 14.0 (StataCorp LP, College Station, TX, USA). To 
detect a 15% difference in the incidence of GDM between 
the intervention (20%) and control groups (35%; α=0.05, 
power=80%), a sample of 280 women (140 in each interven-
tion arm) would be needed. With an assumed dropout rate 
of 40%, the total number needed is ~460.
ethics approval and informed consent
Ethics committees of HUH (September 14, 2006, Dnro 300/
E9/06) and SKCH (September 11, 2008, Dnro M06/08) 
approved the study. The study complied with the Declaration 
of Helsinki. Participants entered into the study voluntarily 
and signed an informed consent form.
Results
We recruited 247 women at high risk for GDM and planning 
pregnancy to the study. The number of women randomized 
was 228 (Figure 1). Of whom, 116 were allocated to the 
intervention group and 112 to the control group. The inclu-
sion criteria were BMI $30 kg/m2 in 46 (20%) women, 
prior GDM in 120 (53%) women, and both in 62 (27%) 
women. The number of women who became pregnant within 
12 months from inclusion was 72 (62%) in the intervention 
group and 71 (63%) in the control group (p=0.84). Two 
(3%) of the pregnancies in the intervention group and three 
(5%) of the pregnancies in the control group began with 
embryo transfer or insemination (p=0.68). No outcome 
data were available for 15 (10%) of the 143 women who 
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conceived, resulting in 128 women for the final analyses 
(Figure 1).
Baseline characteristics of all participants are presented 
in Table 1. No differences were observed in the baseline 
characteristics between randomized women who became 
pregnant compared with those who did not (data not shown), 
but we detected differences within intervention arms. 
Within the control group, women who became pregnant 
demonstrated a 33% obesity rate compared with a 61% obe-
sity rate in women who failed to become pregnant (p=0.003) 
and 87% rate of prior GDM compared with 67% rate of 
prior GDM, respectively (p=0.011). Among the participants 
included in the final analyses, the women in the intervention 
group were more often obese, had a higher waist-to-hip ratio, 
had a higher systolic blood pressure, and had a higher low-
density lipoprotein cholesterol concentration (Table 1).
The cumulative incidence of GDM in the intervention 
group was 60% (n=39) and that in the control group was 54% 
(n=34; p=0.49 and p=0.61, respectively, after adjustments of 
age, BMI, previous GDM status, and the length of preconcep-
tion intervention). The proportion of early GDM (diagnosis 
set in the OGTT performed before 20 weeks of gestation; 
mean 13.3 weeks [SD 2.5 weeks] of gestation) was 64% 
(n=25/39) in the intervention group and 56% (n=19/34) in 
the control group (p=0.47). In the intervention group, 33% 
(13/39) of the women with GDM and in the control group, 
26% (9/34) of the women with GDM needed insulin or met-
formin treatment (p=0.52). Of the participants with GDM in 
the index pregnancy, the proportion of women with prior 
GDM was 90% (n=35/39) in the intervention group and 91% 
(n=31/34) in the control group.
Women belonging to the intervention group had a 
crude reduction in fasting plasma glucose concentration 
of −0.46 mmol/L (95% CI: −0.65 to −0.27 mmol/L) from 
inclusion to the third trimester compared with −0.61 mmol/L 
(95% CI: −0.73 to −0.49 mmol/L) in those belonging 
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Figure 1 Study flow of the participants.
Abbreviation: OgTT, oral glucose tolerance test.
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to the control group (p=0.16 and p=0.77, respectively, 
after adjustments of age, BMI, previous GDM status, the 
length of preconception intervention, and baseline glucose 
concentration).
Gestational weight gain, calculated as weight at the third-
trimester visit minus weight at the last prepregnancy visit, 
was 9.6 kg (95% CI: 7.8 to 11.5) in the intervention group 
and 9.2 kg (95% CI: 7.6 to 10.8) in the control group (p=0.71 
and p=0.93, respectively, after adjustment of age, previous 
GDM status, the length of preconception intervention, and 
baseline weight).
Between the baseline and the first trimester visits, the 
participants in the intervention group increased their self-
reported weekly mean LTPA by 24 minutes (95% CI: −15 
to 63 minutes), whereas the change in the control group was 
negative, −12 minutes (95% CI: −50 to 25 minutes; p=0.18). 
In the intervention group, the participants improved their diet, 
ie, their dietary index increased by 1.2 points (95% CI: 0.4 to 
2.1 points), whereas the change was 0.6 points (95% CI: −0.1 
to 1.4 points) in the control group (p=0.28). Further adjust-
ments did not influence these findings.
In the intervention group, 25 (38%) of the participants and 
in the control group, 33 (52%) of the participants attended 
only one study visit before pregnancy. The mean duration 
between the baseline visit and conception was 4.6 months 
(SD 3.6 months) in the intervention group and 3.8 months 
(SD 3.7 months) in the control group (p=0.26). In the inter-
vention group, participants had on average 2.9 visits (range 
1–6 visits) and in the control group, 2.8 visits (range 1–5 
visits) with the study nurse before the first OGTT in preg-
nancy (p=0.12).
No differences were seen between the groups for obstetric 
or neonatal outcomes (Table 2). Further adjustments did not 
change these results.
Discussion
The need for pre- and interconception care programs, 
including prevention of recurrence of GDM, has been 
Table 1 Baseline characteristics of study participants randomized and included in the final analysis
Variables All randomized women Women included in final analysesa
Intervention (n=116) Control (n=112) Intervention (n=65) Control (n=63)
age (years) 33 (4) 32 (4) 32 (5) 32 (4)
education (years) 14.8 (2.1) 14.4 (1.9) 14.9 (2.2) 14.5 (1.9)
current smoking, n (%) 8 (7) 11 (10) 4 (6) 4 (6)
nulliparous, n (%) 9 (8) 19 (17) 6 (9) 6 (10)
Prior gDM, n (%) 94 (81) 88 (79) 51 (78) 55 (87)
Parental history of diabetes, n (%) 39 (35) 27 (25) 23 (37) 17 (27)
Weight (kg) 83.7 (18.6) 81.1 (18.0) 84.0 (20.0) 78.2 (18.0)
BMI (kg/m2) 30.4 (6.1) 29.4 (5.9) 30.5 (6.3) 28.1 (5.7)*
BMI $30 kg/m2, n (%) 57 (49) 51 (46) 34 (52) 21 (33)*
Waist–hip ratio 0.87 (0.06) 0.85 (0.06) 0.88 (0.07) 0.85 (0.06)*
Metabolic syndrome,b n (%) 44 (38) 40 (36) 26 (40) 24 (41)
Blood pressure (mmHg)
systolic 123 (12) 121 (12) 123 (12) 118 (11)*
Diastolic 81 (8) 79 (8) 82 (8) 79 (9)
Fasting plasma glucose (mmol/l) 5.51 (0.48) 5.47 (0.47) 5.42 (0.49) 5.50 (0.48)
Hba1c (mmol/mol) 36.2 (3.8) 35.0 (3.7) 35.5 (4.1) 34.7 (3.8)
Impaired glucose regulation,c n (%) 20 (17) 17 (16) 9 (14) 9 (14)
serum insulin (mU/l) 9.34 (6.06) 8.55 (7.06) 8.61 (5.44) 8.49 (8.24)
HOMa-Ir 2.33 (1.60) 2.09 (1.81) 2.14 (2.14) 2.12 (2.15)
Total cholesterol (mmol/l) 4.81 (0.82) 4.67 (0.85) 4.78 (0.78) 4.53 (0.81)
lDl cholesterol (mmol/l) 2.96 (0.78) 2.79 (0.74) 2.93 (0.77) 2.62 (0.64)*
HDl cholesterol (mmol/l) 1.39 (0.33) 1.44 (0.36) 1.36 (0.32) 1.47 (0.36)
Total triglycerides (mmol/l) 1.09 (0.58) 1.03 (0.56) 1.10 (0.55) 0.92 (0.48)
Dietary index (points) 9.7 (2.9) 9.9 (2.8) 10.1 (2.8) 10.4 (2.5)
lTPa (min/week) 116 (153) 102 (81) 101 (75) 100 (94)
Notes: Data are reported as mean (sD), unless otherwise indicated. *p,0.05. aParticipants who became pregnant within 1 year after inclusion and had a viable singleton 
pregnancy with primary outcome data available. baccording to nceP criteria. cDefined as IFG (fasting plasma glucose 6.1–6.9 mmol/L) or IGT (2-hour plasma glucose level 
7.8–11.0 mmol/l in 75 g OgTT).
Abbreviations: gDM, gestational diabetes mellitus; BMI, body mass index; Hba1c, hemoglobin a1c; HOMa-Ir, homeostasis model assessment for insulin resistance; lDl, 
low-density lipoprotein; HDl, high-density lipoprotein; lTPa, leisure time physical activity; nceP, national cholesterol education Program; IFg, impaired fasting glucose; 
IgT, impaired glucose tolerance; OgTT, oral glucose tolerance test.
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acknowledged.23,32 The preconceptional lifestyle interven-
tion applied in the RADIEL study did not modify the risk 
for GDM among high-risk women. The incidence of GDM 
was high in both the intervention and the control groups, and 
a majority of the women were diagnosed already in the first 
half of pregnancy.
A preconception intervention study, aiming at improve-
ment in health-related behavior and weight management 
before and during pregnancy, reduced gestational weight 
gain in the intervention group, but the difference between the 
study groups was nonsignificant when adjusted for baseline 
adiposity.33 Another trial with tailored preconception dietary 
and lifestyle counseling reported an improvement in the 
quality of diet and a decrease in harmful behaviors, including 
consumption of alcohol, in subfertile couples, but no preg-
nancy outcomes were reported.34 In a recent trial assessing the 
effect of a 6-month lifestyle intervention before pregnancy 
on the rate of live births within 24 months in obese infertile 
women, a greater weight loss was achieved in the intervention 
group.35 The rate of GDM was a secondary outcome, and no 
difference was observed between the groups.35 To the best of 
our knowledge, no previous intervention study initiated in 
prepregnancy and aiming specifically at prevention of GDM 
has been published.
One strength of this study is that the intervention protocol 
is applicable to a primary healthcare setting. We also man-
aged to recruit high-risk women. In previous T2D prevention 
studies, as well as in our GDM prevention study RADIEL 
initiated in early pregnancy, lifestyle interventions had the 
largest impact on participants with the highest diabetes 
risk.13,24 In this study, 80% of all participants had a history 
of GDM, emphasizing their high risk for GDM, given that 
the reported global recurrence rate of GDM ranges between 
30% and 84%.6
In the present study, the implementation of a prepreg-
nancy intervention turned out to be challenging. During the 
study period, recruiting high-risk women planning pregnancy 
was difficult. This was the case particularly in relation to 
nulliparous women. The most effective method of recruit-
ing participants was by personal invitation letters based on 
information obtained from hospital registries on prior GDM, 
which may have caused a selection bias. In addition, the 
pregnancy rate within 1 year among the participants turned 
out to be low, which complicated the study setting further 
by increasing the dropout rate as compared with assump-
tions made prior to the study. It is further possible that some 
women participating in the trial had changed their intention 
to get pregnant, but we lack data on this possibility. Wishes 
regarding pregnancy can change quickly.36 Information on 
the duration of possible pregnancy attempts before study 
inclusion was also not collected. It is possible that our 
high-risk population presents a group of subfertile women, 
which might have confounded the outcomes. Among women 
with successful pregnancies, however, no difference was 
seen between the intervention and control groups in use of 
infertility treatments. No data were collected regarding the 
possible infertility treatments among women who failed to 
conceive.
The recruitment goal was not reached during the 4-year 
recruitment period. Therefore, the final number of women 
available for the primary outcome analyses, and consequently 
the statistical power, remained too small to reliably establish 
the association between the intervention and GDM incidence. 
Neither the Finnish national guidelines for diagnosis and 
treatment of GDM nor the practice of antenatal care changed 
during the recruitment and follow-up period of the present 
study, reducing the possible effect of the long recruitment 
period on the study.
Table 2 Maternal and neonatal outcomes in the intervention and control groups
Outcome variables Intervention (n=65) Control (n=63) p-value
Maternal pregnancy outcomes
Hypertension before 20 gestational weeks 3 (5) 5 (6) 0.35
Pregnancy-induced hypertension 4 (6) 3 (2) 0.36
Preeclampsia 1 (2) 2 (2) 0.99
Hepatogestosis 1 (2) 1 (2) 0.99
neonatal outcomes
Birth weight (g), mean (sD) 3,682 (498) 3,810 (489) 0.15
Birth weight z-score (sD), mean (sD) 0.35 (1.00) 0.52 (1.04) 0.34
respiratory distress or transient tachypnea of newborn 3 (5) 4 (8) 0.85
congenital malformation 1 (2) 1 (2) 0.99
Note: Data are reported as counts (%), unless otherwise indicated.
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The women who became pregnant and had been allocated 
to the intervention group were more often obese and pre-
sented a more unfavorable lipid profile compared with those 
in the control group, indicating a greater metabolic burden 
in the intervention group, which may have confounded the 
effects of the intervention.
The women with a high risk of GDM form a highly het-
erogeneous group. Although obesity is a well-established risk 
factor for GDM, not all obese women develop GDM. In our 
early pregnancy intervention study, the highest prevalence of 
GDM, 36%, was seen among nonobese participants with prior 
GDM compared with the prevalence among obese women of 
10% for nulliparous and 12% for multiparous without prior 
GDM.37 The proportion of these nonobese women with prior 
GDM in the present study was 53%, which is greater than the 
34% in our early pregnancy intervention.37 The limited size 
of the study population, however, prevents further analyses 
of the subgroups of participants: obese women without his-
tory of GDM, nonobese women with prior GDM, and obese 
women with prior GDM.
A total of 60% of the women with GDM were diagnosed 
already at ~12–16 weeks of gestation. It could be argued that 
a pathologic OGTT during the first half of pregnancy suggests 
preexisting T2D. However, women meeting T2D criteria 
at inclusion were excluded. Furthermore, the most recent 
recommendation of World Health Organization proposes 
differentiating T2D and lesser degrees of hyperglycemia 
(ie, GDM) at any time during pregnancy.38
Compared with women with late-onset GDM, women 
diagnosed with early GDM are known to be more insulin 
resistant already before pregnancy.39 Women with early onset 
of GDM were excluded from our prior study concerning 
the intervention initiated in pregnancy.24 The two different 
study populations, women planning pregnancy and women 
already pregnant, are hence inherently different, which could 
be one explanation for the different outcome between the 
two interventions and lack of an effect of the prepregnancy 
intervention. The proportion of women with prior GDM for 
example was lower in our previous study (33%) compared 
with current study (80%).
A longer and more intense intervention, including more 
frequent contact with study nurses, might have been needed 
to influence the possible preexisting insulin resistance in 
these women before conception. Women in the present study 
needed insulin or metformin treatment more often (30%) 
compared with the 20% of the GDM women (unpublished 
data) included in our prior study,24 further supporting the 
concept of a more severe form of GDM in the current study 
population.
Periconceptional nutrition influences both reproduc-
tive health and pregnancy outcomes as reviewed by Cetin 
et al.40 In our study, 45% of participants included in the final 
analyses had already conceived after the first study visit. 
Therefore, the intervention period might have been too brief 
to improve maternal metabolism during early pregnancy.23 
For the same reason, it was impossible to assess the weight 
loss before pregnancy between the groups. It is also likely 
that the frequency of lifestyle counseling was insufficient to 
have a significant impact on health behavior before and dur-
ing pregnancy, even though the motivation level of women 
planning to conceive, and pregnant women, to make and 
maintain positive lifestyle changes may be enhanced by 
hopes of having a good pregnancy outcome. In addition, the 
intervention was not based on any behavior theory, which 
can be a limitation.
It is worth keeping in mind that all the participants in the 
study were at high risk for GDM and during pregnancy, the 
women in the control group received general health advice and 
visited antenatal clinics outside the study protocol. Further-
more, in the control group, 19 (30%) women with early GDM 
received additional lifestyle counseling in their antenatal 
clinics starting, commencing in the first half of pregnancy. 
In addition, the study follow-up, including repeated measure-
ments, may have acted as a mini-intervention in the control 
group. This may have influenced secondary outcomes such 
as glucose metabolism, quality of diet, and physical activity 
levels in these participants of the control group during the 
follow-up. The weight gain during pregnancy was similar 
and moderate in both groups.
Conclusion
To our knowledge, this is the first study to report a prepreg-
nancy lifestyle intervention trial aiming at GDM prevention. 
Even though a lifestyle intervention initiated in the first half 
of pregnancy showed a 36% reduction in the incidence of 
GDM,24 the same type of intervention initiated before con-
ception failed to show any effect on GDM incidence. Many 
elements complicated the implementation of the study, and 
the incidence of early GDM was considerably high in our 
cohort of high-risk women.
More studies assessing preconceptional lifestyle interven-
tions are needed. It is possible that a longer, more intensive, 
and more frequent lifestyle intervention in the preconception 
period in a larger study population would have an impact 
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on the incidence of GDM and on perinatal and neonatal 
outcomes.23 Future prevention trials need to take the problems 
of recruitment and low pregnancy rates observed in the cur-
rent trial into account and consider the possibility of applying 
more intense interventions.
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